IL129141A0 - Use of 1-hydroxy-2- pyridone for the treatment of seborrheic dermatitis - Google Patents

Use of 1-hydroxy-2- pyridone for the treatment of seborrheic dermatitis

Info

Publication number
IL129141A0
IL129141A0 IL12914197A IL12914197A IL129141A0 IL 129141 A0 IL129141 A0 IL 129141A0 IL 12914197 A IL12914197 A IL 12914197A IL 12914197 A IL12914197 A IL 12914197A IL 129141 A0 IL129141 A0 IL 129141A0
Authority
IL
Israel
Prior art keywords
pyridone
hydroxy
treatment
seborrheic dermatitis
seborrheic
Prior art date
Application number
IL12914197A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL129141A0 publication Critical patent/IL129141A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Pyridine Compounds (AREA)
IL12914197A 1996-09-27 1997-09-16 Use of 1-hydroxy-2- pyridone for the treatment of seborrheic dermatitis IL129141A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19639818A DE19639818A1 (de) 1996-09-27 1996-09-27 Verwendung von 1-Hydroxy-2-pyridonen zur Behandlung der Seborrhoischen Dermatitis
PCT/EP1997/005070 WO1998013009A2 (de) 1996-09-27 1997-09-16 Verwendung von 1-hydroxy-2-pyridonen zur behandlung der seborrhoischen dermatitis

Publications (1)

Publication Number Publication Date
IL129141A0 true IL129141A0 (en) 2000-02-17

Family

ID=7807118

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12914197A IL129141A0 (en) 1996-09-27 1997-09-16 Use of 1-hydroxy-2- pyridone for the treatment of seborrheic dermatitis

Country Status (32)

Country Link
EP (1) EP0928183B1 (zh)
JP (2) JP2001500884A (zh)
KR (1) KR100494207B1 (zh)
CN (1) CN1104231C (zh)
AR (1) AR008860A1 (zh)
AT (1) ATE209891T1 (zh)
AU (1) AU716208B2 (zh)
BG (1) BG64365B1 (zh)
BR (1) BR9711575A (zh)
CA (1) CA2267165C (zh)
CY (1) CY2362B1 (zh)
CZ (1) CZ291485B6 (zh)
DE (2) DE19639818A1 (zh)
DK (1) DK0928183T3 (zh)
ES (1) ES2167721T3 (zh)
HK (1) HK1022267A1 (zh)
HU (1) HU226955B1 (zh)
ID (1) ID21874A (zh)
IL (1) IL129141A0 (zh)
MA (1) MA24333A1 (zh)
MY (1) MY125674A (zh)
NO (1) NO312492B1 (zh)
NZ (1) NZ334850A (zh)
OA (1) OA11028A (zh)
PL (1) PL188033B1 (zh)
PT (1) PT928183E (zh)
RS (1) RS49801B (zh)
TR (1) TR199900662T2 (zh)
TW (1) TW519491B (zh)
UA (1) UA57754C2 (zh)
WO (1) WO1998013009A2 (zh)
ZA (1) ZA978640B (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040039030A1 (en) 1996-09-27 2004-02-26 Hoechst Akeengesellschaft Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
DE19639816A1 (de) 1996-09-27 1998-04-02 Hoechst Ag Antimykotische Mittel mit hoher Wirkstofffreisetzung
US20050095215A1 (en) * 2003-11-03 2005-05-05 Popp Karl F. Antimicrobial shampoo compositions
PL2197440T3 (pl) 2007-08-31 2013-05-31 Janssen Pharmaceutica Nv Kombinacje imazalilu i hydroksypirydonów
BRPI0819858A2 (pt) 2007-11-30 2014-10-07 Janssen Pharmaceutica Nv Composições de triazóis fungicidas e compostos pirion
CA2711762C (en) 2008-02-06 2016-11-01 Jan Pieter Hendrik Bosselaers Combinations of phenylpyrroles and pyrion compounds
US9237749B2 (en) 2010-07-01 2016-01-19 Janssen Pharmaceutica N.V. Antimicrobial combinations of pyrion compounds with polyethyleneimines
ES2573116T3 (es) * 2010-12-02 2016-06-06 The University Of Kansas Profármacos de 6-ciclohexil-1-hidroxi-4-metilpiridin-2(1H)-ona y sus derivados
CN103687582B (zh) * 2011-07-19 2016-03-30 露珍细胞再生株式会社 含有从酵母菌中提取出的多聚磷酸、多聚磷酸的盐或多聚磷酸的溶剂化物的多聚磷酸组合物及其制作方法
FR2983858B1 (fr) * 2011-12-08 2014-01-03 Fabre Pierre Dermo Cosmetique Nouveaux composes inhibiteurs de la lipogenese
CN104744359B (zh) * 2015-03-06 2017-10-10 上药康丽（常州）药业有限公司 一种环吡酮的精制方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2234009C3 (de) * 1972-07-11 1979-01-11 Hoechst Ag, 6000 Frankfurt Kosmetische Zubereitungen
NL8601762A (nl) * 1986-07-07 1988-02-01 Bouke Jan Lange Werkwijze voor de reiniging en conditionering en eventuele medicinale behandeling van het haar en de hoofdhuid, een voor dit doel bruikbare tweefasen shampoo, alsmede een verpakking daarvoor.
JP2871856B2 (ja) * 1992-09-08 1999-03-17 ザ、プロクター、エンド、ギャンブル、カンパニー マイルドで実質上無色のシャンプー組成物
DE4333893A1 (de) * 1993-10-05 1995-04-06 Hoechst Ag Kosmetische Zubereitungen
FR2722689B1 (fr) * 1994-07-20 1996-10-04 Fabre Pierre Dermo Cosmetique Nouveau produit de combinaison comprenant un agent antifongique et du crotamiton comme potentialisateur de l'activite de l'agent antifongique, et compositions dermatologiques et/ou cosmetiques le comprenant

Also Published As

Publication number Publication date
ID21874A (id) 1999-08-05
AU716208B2 (en) 2000-02-24
ATE209891T1 (de) 2001-12-15
HU226955B1 (en) 2010-03-29
TW519491B (en) 2003-02-01
YU13499A (sh) 2001-09-28
CN1104231C (zh) 2003-04-02
UA57754C2 (uk) 2003-07-15
BR9711575A (pt) 1999-08-24
HUP9903811A1 (hu) 2000-04-28
DE59705697D1 (de) 2002-01-17
NO991460D0 (no) 1999-03-25
CY2362B1 (en) 2004-06-04
ZA978640B (en) 1998-03-27
NO991460L (no) 1999-03-25
CA2267165C (en) 2003-12-16
PL188033B1 (pl) 2004-11-30
DK0928183T3 (da) 2002-04-02
CA2267165A1 (en) 1998-04-02
RS49801B (sr) 2008-06-05
MA24333A1 (fr) 1998-04-01
CN1231595A (zh) 1999-10-13
AR008860A1 (es) 2000-02-23
DE19639818A1 (de) 1998-04-02
BG103260A (en) 2000-01-31
PT928183E (pt) 2002-05-31
HUP9903811A3 (en) 2001-11-28
KR100494207B1 (ko) 2005-06-13
CZ107599A3 (cs) 1999-06-16
AU4774697A (en) 1998-04-17
JP2001500884A (ja) 2001-01-23
HK1022267A1 (en) 2000-08-04
NO312492B1 (no) 2002-05-21
WO1998013009A3 (de) 1998-05-14
NZ334850A (en) 2001-02-23
TR199900662T2 (xx) 1999-06-21
OA11028A (fr) 2003-03-06
ES2167721T3 (es) 2002-05-16
KR20000048613A (ko) 2000-07-25
EP0928183B1 (de) 2001-12-05
BG64365B1 (bg) 2004-12-30
WO1998013009A2 (de) 1998-04-02
PL332603A1 (en) 1999-09-27
JP2006176540A (ja) 2006-07-06
EP0928183A2 (de) 1999-07-14
CZ291485B6 (cs) 2003-03-12
MY125674A (en) 2006-08-30

Similar Documents

Publication Publication Date Title
AU3441197A (en) 3-ureido-pyridofurans and -pyridothiophenes for the treatment of inflammatory processes
ZA993364B (en) Novel 4-phenylpiperidines for the treatment of pruritic dermatoses.
PL345338A1 (en) Method for the treatment of insomnia
IL136110A0 (en) Methods and compositions for the treatment of psoriasis
IL126696A0 (en) Azetidinone derivatives for the treatment of atherosclerosis
ZA978639B (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections.
IL129141A0 (en) Use of 1-hydroxy-2- pyridone for the treatment of seborrheic dermatitis
PL345769A1 (en) Triazolopyridines for the treatment of thrombosis disorders
HUP0200738A3 (en) Method of the treatment of incontinence
AU1697197A (en) Immunoconjugate for the treatment of aids
AU7310896A (en) Use of nitroflavonoids for the treatment of anxiety
AU3814599A (en) Use of erythropoietin for the treatment of haemochromatoses
ZA976350B (en) Treatment of liquid.
IL112469A0 (en) Composition for the treatment of an epidermal disorder
ZA200110474B (en) Method and device for the continuous of NaAlCl4 or NaFeCl4.
AU2510197A (en) Solid agent for the treatment of keratinous fibres
SI0928183T1 (en) Use of 1-hydroxy-2-pyridone for the treatment of seborrheic dermatitis
HK1043938A1 (en) Composition for the treatment of psoriasis
ZA976071B (en) Process for the monoacylation of hydroxytaxanes.
ZA978139B (en) Process for the biological-thermal treatment of waste.
ZA974386B (en) New formulation for treatment of thromboembolism.
GB2286716B (en) The treatment of solid wastes
HK1004660A1 (en) Composition for treating hyperosteogeny and process for the preparation thereof
SI1068199T1 (en) N-aryloxyethyl-indoly-alkylamines for the treatment of depression
PL345201A1 (en) Method for the treatment of waste

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
EXP Patent expired